Member Info for notaflipper

The BoE is expected to increase interest rates on Thursday to above 1% to either to 1.25%, or even to 1.5% on Thursday. Have to figure some negativity in market sentiment, and not favourable to a trading update that still says "Work In Progress" given how badly the December update was received. Even though this was just a repeat of the Half Year Results in August, holders were punished here. Would rather that they awaited to just get the job done as confirm that debt had been reduced (by £100m to £200m) from disposals and that this is not going to Working Capital. Have to feel markets may be a bit turbulent next week at the macro level because of inflationary fears so FTSE could turn negative IMHO.

lot's of (potential) news to discuss it seems

Indeed @Cashola market is down due to worries that "post-pandemic spending bubble has burst".

The British Retail Consortium (BRC) has May LFL sales down 1.5% from -1.7% in April while actual spending overall gained 9.3% reflecting the rising cost of living and base effects, with the BRC chief states that "it is clear the post-pandemic spending bubble has burst".

To be fair to @Aim, overall FTSE is down this year-to-date, so there's still bargains out there (e.g. IAG may slip below 120p this week) and there's no harm in staying in Cash till you see which sector recovers quicker. We should start seeing momentum here in the next month in advance of trading update though. GLA

Well the Results are in, and whatever your preference looks like BoJo cannot be challenged again till next Summer, though it seems most expect a forced resignation by Autumn. Sterling rose sharply in early morning trading once vote of confidence was announced, and then traced-back through the day. It will be interesting to see how this trades as could indicate movement of FTSE tomorrow.

The issue is that if BoJo looses the vote of confidence, there'll have to be another general election following a Tory Leadership contest, if you follow what happened after Teresa May. Sterling rose 0.6% to 1.26 US dollars and 0.4% to 1.17 euros after leadership contest announced. Results should be announced later tonight, and I am expecting BoJo to win by a thin margin, or potentially lose. The chappies publicly coming out against Bojo are past Insiders, so have to think that the PM will lose.

Tube strike was a 'cold water' wake-up call after the 4-day weekend. Markets seem to be expecting that Boris Johnson will win his no confidence vote this week.

Anyone expecting any further news before AGM?

Pretty disappointed, even though this now seems to be the norm here.

This was all jam tomorrow, and must have been pretty embarrassing for the IR who drafted this.

· Commercial partnership for Lupuzor (P140) outside of US in key territories ~ "we'll get back to you, at some point"
· Commercial partnership for CIDP ~ "we'll get back to you, at some point"
· Commercial partnership for BioAMB ~ "we'll get back to you, at some point"

Cash at bank should be enough to pay for general administrative expenses till the above lands and the sp will be at a higher point. I suspect the inflated administrative expenses for the re-organisation, were inflated by pay-offs.

Delayed Results probably points that they were expecting some of the above to conclude before now, so I suspect we are not far off. Hopefully

For a share which is not going to go anywhere for a few years, the share board does attract a lot of well-wishers providing helpful education to us naïve investors. Guess we are lucky.
Bit disappointed not to hear anything this week regarding Final Results. I am not sure when the deadline to supply this will be. Main thing within we are all wanting to hear is an update on commercialisation and P3 Study arrangement with FDA.

This has further to drop - sorry. The Dow has declined for seven straight weeks and is down 13% in 2022. The Nasdaq is down 27% this year. S&P 500 futures dropped 0.8% a day after the benchmark closed at 3,923.68, or 18.6% below its intraday record reached in January. It also sits around 18% below its record closing level. A close of 20% or more below its all-time high would mark a bear market, its first since the March 2020 pandemic sell-off. So I suspect at some point this will eventually slip to a bear market and then a chain reaction will kick-off. Main thing here is to be patient for a week or so, then rinse and repeat. Eventually though by Summer Trading update all should come good.

...update must come this week? Time to give TM a nudge to wake up.

Cheers, but should have waited. Markets completely red today as suffering from US led nervousness, and as the crypto bubble continues to burst as the likes of Dogecoin and Shiba slide down towards all time lows. So $1 Trillion wiped off on Bitcoin, Ethereum, BNB, XRP, Cardano, Solana, Terra’s Luna. Sell-off comes after the $18 billion algorithmic stablecoin terra lost its peg to the U.S. dollar, wiping out the price of its support coin luna which has now lost almost 99% of its value. This is in addition to UK preliminary GDP numbers coming in at 8.7% year on year, under the forecasts of around 9%.

https://polaris.brighterir.com/public/capita/news/rns/story/w6d5dgx

It was mentioned that this week will bring further buying opportunities. Markets are too crazy to call bottom.
IAG is 125p, RR is sub 80p, BARC is 145p. All these levels are not far off their worst levels at the height of pandemic. Fun never ends, just need to trade throughout or sink if not swimming.
GLA

To be fair I also feel news is imminent here, hence the holding RNS last week. What the impact will be I hazard to say, given the poor response since last December. That said, it does feel like we are stuck in a 'whack-a-mole-' scenario, where anytime there seems any momentum on the sp, it gets knocked down again. Yesterday, to be fair to your enthusiasm was a classic case in point.

Think there'll be a few more buying opportunities this week given the US and Asian markets performance. CPI board has been the graveyard of many LSE accounts, from posters who've called it wrong in a spectacular way and had to change aliases. Tend to agree with the cautionary voices here that till the transformation is complete then there's little chance of a share buy back. Have to think why JL would sell 572,264 shares if there'd be a buy back scheduled on his and the new Chairman's instruction.
Separately some interesting comments from Belarus over the weekend that they had thought the war had dragged on to long. So with the potential NATO expansion this month with Sweden/Finland, it could be that some conclusion is found in the next month or so.

Looks like a Buy that was worked through the day via a broker to sit on mid between the Bid and Ask to not affect the sp. Have to imagine if it was a Sell, that with the low volumes it would have reduced the Bid more significantly. However each to their own interpretations.

Cheers @dallo,
Late reported buy of 450k shares after hours. Hopefully points to news next week.

Any trader here will post comments to support there trading pattern, share investment priorities, availability of funds and so on.

There has been some interesting points to note, however most overlook that some PIs here have more modest sp targets. Clearly the sp performance is lacklustre and not far off historical lows despite news on the PK Study and the successful placing. The poor sp performance is underlined by being 50% below the Benchmark Price of 14.6667p of the Lanstead Sharing Agreement. And so, the Company is therefore getting less than 50% of the monthly £91,667 settlement. TM with his Quarterly updates has been poor in articulating the investment opportunity or generating interest. It is suspected though that news should follow soon hence the delay in Results and the holding RNS update on the 04th to say that they were in final negotiations with the FDA on the structure of the Lupuzor Phase 3 trials. Hopefully this update will finally include updates on the commercialisation of BioAMB and BioCin, as these commercial discussions have been alluded to now for 2 Quarters.

As mentioned the announcement of FDA approval is a target for those with more modest sp aspirations. Before the conclusion of the P3 trials on Lupuzor, the CIDP programme with their much shorter clinical timelines could reach registration and commercialisation up to a year earlier than the Lupus indication. So it is likely that IMM will be bought before the conclusion of the Lupus P3 trials.

For now just getting the Benchmark Price of 14.6667p would be a major sp milestone that many PIs would welcome.

Think some one said this.
Sigh.
Will have to see what happens on May 9th as an important day for Putin to make a statement to his own internal audience, and there may be a further 'wobble'. The truth of the matter is that this is a trader's share till the Summer trading update, and one has to take advantage of the swings till then rather than holding for a bull run 30p+